Cost Effectiveness of Implementing a Universal Birth Hepatitis B Vaccination Program in Ontario.
John J KimWasem AlsabbaghWilliam W L WongPublished in: PharmacoEconomics (2023)
Our analysis suggests that changing the age of the hepatitis B vaccination recommendation from adolescent to newborn is cost effective and mostly a cost-saving strategy. Newborn vaccination may lead to cost and health benefits while aligning with best available evidence and guidance from the World Health Organization.